Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Trichotillomania is more common than previously thought, with increasing diagnosed cases.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Saw palmetto is not proven to improve urinary flow, prostate size, or hair loss.

Topical minoxidil 1% and 2% are twice as effective as placebo for female pattern hair loss.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Patients need long-term care after bariatric surgery to manage potential nutritional and metabolic issues.

Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.

Early hair loss may indicate risk of insulin resistance.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.

A wearable device using electric stimulation can significantly improve hair growth.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Finasteride treats enlarged prostate, shrinks it, improves urination, but may cause sexual dysfunction and isn't for women or children.